Pure Global AI
NCT06294483Enrolling by invitation

Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.

Comparison of Clinical Features, Hematological Indices and Disease Activity Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
Sohag UniversityClinicalTrials.govdiagnostic test
Study focus
Drug/Device/Intervention
CBC
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sohag University
Location
Sohag, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jan 10, 2024
End date
Aug 30, 2024
Enrollment
100 participants
Primary outcome

Evaluate the hematological indices as (mean platelet volume) of our SLE patient.,Evaluate the hematological indices as (neutrophil lymphocyte ratio) of our SLE patient.,Evaluate the hematological indices ( platelet lymphocyte ratio ) of our SLE patient.,Compare the degree of disease activity between the early-onset and late-onset patients with systemic lupus erythematosus.,Evaluate the correlation between hematological indices (mean platelet volume, platelet lymphocyte ratio and neutrophil lymphocyte ratio) and Systemic lupus erythematosus (SLE) disease manifestations and activity.

Summary

The present study aims to:
 
 Compare clinical features, hematological indices and disease activity between the early-onset
 and late-onset patients with systemic lupus erythematosus.
 
 Evaluate the relationship between hematological indices (mean platelet volume, platelet
 lymphocyte ratio and neutrophil lymphocyte ratio) and Systemic lupus erythematosus (SLE)
 disease manifestations and activity.

ICD-10 classifications
Systemic lupus erythematosusSystemic lupus erythematosus, unspecifiedLupus erythematosusSystemic lupus erythematosus with organ or system involvementOther forms of systemic lupus erythematosus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06294483
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06294483 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Enrolling by invitation. The study focuses on Systemic Lupus Erythematosus. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.